Stage IIIB Colorectal Cancer Recruiting Phase 2 Trials for Ibuprofen (DB01050)

IndicationStatusPhase
DBCOND0068494 (Stage IIIB Colorectal Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03186638Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Non-metastatic Colorectal Cancer Receiving ChemotherapySupportive Care